"Trust-worthy, independent, patient-focused, University of Michigan-trained Dermatologist committed to provide exceptional patient care for our community! Proud to be affiliated with all major healthcare systems and having the most caring staff in the business! We strive to be the complete skin care expert for you, your family and your friends!"

During the past decade, Michigan Dermatology Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Michigan Dermatology Institute" are "Arthritis, Juvenile" (1 trials), "Atopic Dermatitis" (1 trials), "Discoid Lupus Erythematosus" (1 trials), "Juvenile Psoriatic Arthritis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Michigan Dermatology Institute" in a lesser frequency.

Most popular intervention types in "Michigan Dermatology Institute" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Daxdilimab" (1 trials), "Placebo/Daxdilimab" (1 trials), "Ruxolitinib" (1 trials), "Ustekinumab" (1 trials) and "Vehicle Cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Dermatology Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Dermatology Institute". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Michigan Dermatology Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Dermatology Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".